KR20240090983A - 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도 - Google Patents
신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도 Download PDFInfo
- Publication number
- KR20240090983A KR20240090983A KR1020247017446A KR20247017446A KR20240090983A KR 20240090983 A KR20240090983 A KR 20240090983A KR 1020247017446 A KR1020247017446 A KR 1020247017446A KR 20247017446 A KR20247017446 A KR 20247017446A KR 20240090983 A KR20240090983 A KR 20240090983A
- Authority
- KR
- South Korea
- Prior art keywords
- nerve
- isorhoifolin
- derivatives
- brain
- nerve damage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/06—Benzopyran radicals
- C07H17/065—Benzo[b]pyrans
- C07H17/07—Benzo[b]pyran-4-ones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0085—Brain, e.g. brain implants; Spinal cord
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Otolaryngology (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163271411P | 2021-10-25 | 2021-10-25 | |
| US63/271,411 | 2021-10-25 | ||
| PCT/CN2022/127372 WO2023072069A1 (zh) | 2021-10-25 | 2022-10-25 | 异野漆树苷及其衍生物用于促进神经修复的用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20240090983A true KR20240090983A (ko) | 2024-06-21 |
Family
ID=86159046
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247017446A Pending KR20240090983A (ko) | 2021-10-25 | 2022-10-25 | 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도 |
| KR1020247017445A Pending KR20240090982A (ko) | 2021-10-25 | 2022-10-25 | 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020247017445A Pending KR20240090982A (ko) | 2021-10-25 | 2022-10-25 | 이소프로필-d-글루코피라노사이드 유도체, 이의 제조방법과 용도 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20250255893A1 (https=) |
| EP (2) | EP4424695A4 (https=) |
| JP (2) | JP2024541121A (https=) |
| KR (2) | KR20240090983A (https=) |
| CN (2) | CN118139869A (https=) |
| TW (2) | TWI898161B (https=) |
| WO (2) | WO2023072069A1 (https=) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101045072A (zh) * | 2007-05-08 | 2007-10-03 | 胡军 | 山香圆叶提取物及其医药用途 |
| CN102617658B (zh) * | 2012-03-09 | 2014-08-20 | 中国烟草总公司郑州烟草研究院 | β-紫罗兰醇-β-D-葡糖苷的制备方法及其在烟草加香中的应用 |
| CN102617659A (zh) * | 2012-03-09 | 2012-08-01 | 中国烟草总公司郑州烟草研究院 | α-紫罗兰醇葡糖苷的合成方法及其在卷烟中的加香应用 |
| CN106167508A (zh) * | 2016-07-13 | 2016-11-30 | 上海应用技术学院 | 一种具有紫罗兰香味的葡萄糖苷化合物及其制备方法 |
-
2022
- 2022-10-25 KR KR1020247017446A patent/KR20240090983A/ko active Pending
- 2022-10-25 US US18/704,860 patent/US20250255893A1/en active Pending
- 2022-10-25 CN CN202280071353.3A patent/CN118139869A/zh active Pending
- 2022-10-25 TW TW111140498A patent/TWI898161B/zh active
- 2022-10-25 WO PCT/CN2022/127372 patent/WO2023072069A1/zh not_active Ceased
- 2022-10-25 JP JP2024547816A patent/JP2024541121A/ja active Pending
- 2022-10-25 US US18/704,869 patent/US20240415859A1/en active Pending
- 2022-10-25 EP EP22885946.8A patent/EP4424695A4/en active Pending
- 2022-10-25 TW TW111140500A patent/TW202317142A/zh unknown
- 2022-10-25 JP JP2024547815A patent/JP2024539499A/ja active Pending
- 2022-10-25 KR KR1020247017445A patent/KR20240090982A/ko active Pending
- 2022-10-25 WO PCT/CN2022/127414 patent/WO2023072085A1/zh not_active Ceased
- 2022-10-25 EP EP22885962.5A patent/EP4424694A4/en active Pending
- 2022-10-25 CN CN202280071472.9A patent/CN118215669A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| TW202317142A (zh) | 2023-05-01 |
| US20240415859A1 (en) | 2024-12-19 |
| JP2024541121A (ja) | 2024-11-06 |
| CN118215669A (zh) | 2024-06-18 |
| KR20240090982A (ko) | 2024-06-21 |
| TWI898161B (zh) | 2025-09-21 |
| WO2023072085A1 (zh) | 2023-05-04 |
| EP4424694A1 (en) | 2024-09-04 |
| EP4424695A1 (en) | 2024-09-04 |
| EP4424694A4 (en) | 2026-03-11 |
| JP2024539499A (ja) | 2024-10-28 |
| EP4424695A4 (en) | 2025-10-22 |
| TW202320806A (zh) | 2023-06-01 |
| WO2023072069A1 (zh) | 2023-05-04 |
| CN118139869A (zh) | 2024-06-04 |
| US20250255893A1 (en) | 2025-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhai et al. | Reducing complement activation during sleep deprivation yields cognitive improvement by dexmedetomidine | |
| CN112646774B (zh) | 用线粒体特化细胞治疗神经退行性疾病的医药组合物 | |
| Woch et al. | Retinal transplants restore visually evoked responses in rats with photoreceptor degeneration | |
| US20140099286A1 (en) | Cell therapy for chronic stroke | |
| Shao et al. | IL-10 and IL-1β mediate neuropathic-pain like behavior in the ventrolateral orbital cortex | |
| CN109937053B (zh) | 用于治疗黄斑变性的含有mTOR抑制剂的药物组合物 | |
| CN113473983A (zh) | 通过施用树脂毒素治疗帕金森病的方法 | |
| Tang et al. | Hypoxic preconditioned mesenchymal stem cells ameliorate rat brain injury after cardiopulmonary resuscitation by suppressing neuronal pyroptosis | |
| Liu et al. | A novel rat model of ocular hypertension by a single intracameral injection of cross‐linked hyaluronic acid hydrogel (Healaflow®) | |
| Heng et al. | BDNF and cAMP are neuroprotective in a porcine model of traumatic optic neuropathy | |
| WO2016125330A1 (ja) | 網膜再生促進薬 | |
| KR20240090983A (ko) | 신경 복원 촉진에 사용되는 이소로이폴린 및 그 유도체의 용도 | |
| JP2005505548A (ja) | 神経細胞変性の病気の治療のためのβ−アドレナリン受容体拮抗薬を使用する方法 | |
| KR20260049790A (ko) | 신경 손상 복구 제품의 제조에서의 2가 금속 락테이트의 용도 | |
| Li et al. | Effects of l-dopa methyl ester on visual cortex injury induced by amblyopia and its underlying mechanism | |
| CN107296808B (zh) | 化合物埃博霉素b在制备修复角膜神经创伤的药物中的应用 | |
| Wang et al. | Olfactory mucosa mesenchymal stem cell‐derived exosomes protect against neuroinflammation after subarachnoid hemorrhage by activating mitophagy | |
| RU2129427C1 (ru) | Способ лечения заболеваний центральной нервной системы | |
| Byrd et al. | Potential mechanisms for osteopathic manipulative treatment to alleviate migraine-like pain in female rats | |
| JP2024539499A5 (https=) | ||
| EP1180036B1 (en) | Cell therapy for chronic stroke | |
| Hassler et al. | Intention Myoclonus of Multiple Sclerosis, its Patho-anatomical Basis and its Stereotactic Relief: Remarks concerning the precipitation of new demyelinating foci | |
| CN111840519B (zh) | 脑源性神经营养因子用于制备防治丙泊酚成瘾药物的用途 | |
| RU2347578C1 (ru) | Способ лечения ушиба головного мозга | |
| JP2001511136A (ja) | Cm101/gbs毒素による神経損傷の修復の促進 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| P11-X000 | Amendment of application requested |
St.27 status event code: A-2-2-P10-P11-nap-X000 |
|
| P13-X000 | Application amended |
St.27 status event code: A-2-2-P10-P13-nap-X000 |
|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| R11 | Change to the name of applicant or owner or transfer of ownership requested |
Free format text: ST27 STATUS EVENT CODE: A-3-3-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE) |